BR112012003209A2 - composições e métodos para tratar infecção fúngica da unha - Google Patents
composições e métodos para tratar infecção fúngica da unhaInfo
- Publication number
- BR112012003209A2 BR112012003209A2 BR112012003209A BR112012003209A BR112012003209A2 BR 112012003209 A2 BR112012003209 A2 BR 112012003209A2 BR 112012003209 A BR112012003209 A BR 112012003209A BR 112012003209 A BR112012003209 A BR 112012003209A BR 112012003209 A2 BR112012003209 A2 BR 112012003209A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- treating fungal
- fungal nail
- nail infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23355709P | 2009-08-13 | 2009-08-13 | |
| PCT/SE2010/050886 WO2011019317A1 (en) | 2009-08-13 | 2010-08-13 | Compositions and methods for treating fungal infection of the nail |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012003209A2 true BR112012003209A2 (pt) | 2016-03-01 |
Family
ID=43586315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012003209A BR112012003209A2 (pt) | 2009-08-13 | 2010-08-13 | composições e métodos para tratar infecção fúngica da unha |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120129942A1 (pt) |
| EP (1) | EP2464334A4 (pt) |
| JP (1) | JP2013501780A (pt) |
| KR (1) | KR20120038444A (pt) |
| CN (1) | CN102470102A (pt) |
| AU (1) | AU2010283031A1 (pt) |
| BR (1) | BR112012003209A2 (pt) |
| CA (1) | CA2764236A1 (pt) |
| IL (1) | IL217845A0 (pt) |
| MX (1) | MX2012001766A (pt) |
| RU (1) | RU2011150901A (pt) |
| SG (1) | SG177750A1 (pt) |
| WO (1) | WO2011019317A1 (pt) |
| ZA (1) | ZA201108753B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2478159A (en) * | 2010-02-26 | 2011-08-31 | Lrc Products | Composition for the treatment of fungal nail infection |
| WO2012110430A1 (en) * | 2011-02-10 | 2012-08-23 | Moberg Derma Ab | Novel composition for topical use on a nail |
| AU2012215383B2 (en) * | 2011-02-11 | 2016-06-09 | Moberg Pharma Ab | Novel antifungal composition |
| WO2014140507A1 (en) | 2013-03-15 | 2014-09-18 | Moberg Pharma Ab | Pharmaceutical composition for the treatment of fungal infections |
| GB201416727D0 (en) * | 2014-09-22 | 2014-11-05 | Novabiotics Ltd | Use |
| US10543276B2 (en) | 2016-08-08 | 2020-01-28 | Marlinz Pharma, LLC | Topical compositions |
| US10206962B1 (en) | 2016-08-08 | 2019-02-19 | Marlinz Pharma, LLC | Method for treating fungal infections in nails |
| EP3897604A4 (en) * | 2018-12-19 | 2022-08-17 | Marlinz Pharma, LLC | TOPICAL COMPOSITIONS |
| KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4212105A1 (de) * | 1992-04-10 | 1993-10-14 | Roehm Pharma Gmbh | Nagellack zur Behandlung von Onychomykosen |
| US5696164A (en) * | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
| US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| KR20000045198A (ko) * | 1998-12-30 | 2000-07-15 | 김수지 | 항진균성 손톱 와니스 |
| US7074392B1 (en) * | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
| US8486426B2 (en) * | 2002-07-29 | 2013-07-16 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for treatment of dermal conditions |
| PT1545619E (pt) * | 2002-09-05 | 2008-02-28 | Galderma Sa | Solução destinada a uma aplicação sobre as unhas |
| EP2457560A1 (en) * | 2006-06-14 | 2012-05-30 | Dr Reddy's Laboratories Limited | Topical compositions |
| EP2124878B1 (en) * | 2007-02-05 | 2015-09-02 | Biophile Corporation, Ltd | Increased effectiveness of allylamine drug compounds |
| US20090175810A1 (en) * | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
-
2010
- 2010-08-13 WO PCT/SE2010/050886 patent/WO2011019317A1/en not_active Ceased
- 2010-08-13 CA CA2764236A patent/CA2764236A1/en not_active Abandoned
- 2010-08-13 AU AU2010283031A patent/AU2010283031A1/en not_active Abandoned
- 2010-08-13 CN CN2010800360469A patent/CN102470102A/zh active Pending
- 2010-08-13 EP EP10808425.2A patent/EP2464334A4/en not_active Withdrawn
- 2010-08-13 BR BR112012003209A patent/BR112012003209A2/pt not_active IP Right Cessation
- 2010-08-13 MX MX2012001766A patent/MX2012001766A/es not_active Application Discontinuation
- 2010-08-13 SG SG2012005344A patent/SG177750A1/en unknown
- 2010-08-13 US US13/383,510 patent/US20120129942A1/en not_active Abandoned
- 2010-08-13 RU RU2011150901/15A patent/RU2011150901A/ru not_active Application Discontinuation
- 2010-08-13 JP JP2012524678A patent/JP2013501780A/ja active Pending
- 2010-08-13 KR KR1020127001212A patent/KR20120038444A/ko not_active Withdrawn
-
2011
- 2011-11-29 ZA ZA2011/08753A patent/ZA201108753B/en unknown
-
2012
- 2012-01-30 IL IL217845A patent/IL217845A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2764236A1 (en) | 2011-02-17 |
| RU2011150901A (ru) | 2013-09-20 |
| SG177750A1 (en) | 2012-03-29 |
| EP2464334A1 (en) | 2012-06-20 |
| ZA201108753B (en) | 2012-08-29 |
| IL217845A0 (en) | 2012-03-29 |
| EP2464334A4 (en) | 2014-03-26 |
| KR20120038444A (ko) | 2012-04-23 |
| CN102470102A (zh) | 2012-05-23 |
| WO2011019317A1 (en) | 2011-02-17 |
| JP2013501780A (ja) | 2013-01-17 |
| MX2012001766A (es) | 2012-03-07 |
| AU2010283031A1 (en) | 2012-01-19 |
| US20120129942A1 (en) | 2012-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BR112012004979A2 (pt) | composições para o tratamento de semente e métodos | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| BRPI1011325A2 (pt) | composições e métodos para o tratamento de inflamação | |
| BRPI0908854A2 (pt) | composições e métodos para o tratamento de tumor de origem hematopoética | |
| BR112013023027A2 (pt) | composições e métodos para esmaltes de unha curáveis por uv | |
| BR112013010725A2 (pt) | método, e, composição | |
| BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
| BRPI0921959A2 (pt) | métodos e composições para remoção de tatuagem | |
| PL2356462T3 (pl) | Kompozycje anty-CXCR1 oraz sposoby | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
| FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
| PT2512502T (pt) | Métodos e composições para supressão de tumores | |
| BRPI1007477A2 (pt) | método, e, composição de tratamento de poço | |
| BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| PT2632452T (pt) | Compostos e composições para o tratamento do cancro | |
| BRPI1007667A2 (pt) | condicionador capilar e composição | |
| BRPI1008326A2 (pt) | Composições e métodos para controlar nanatódeos | |
| BRPI0822349A2 (pt) | composições e métodos para tratar doenças lisossômicas | |
| BRPI1007600A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BRPI1013927A2 (pt) | métodos e composições para o tratamento de lúpus | |
| BR112013006232A2 (pt) | processo de tratamento cosmético, composto e composição cosmética | |
| BRPI1014488A2 (pt) | composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas | |
| IL217845A0 (en) | Compositions and methods for treating fungal infection of the nail |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2377 DE 26-07-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |